Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04774952 |
| Title | Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Revolution Medicines, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UC Irvine - Chao Family Comprehensive Cancer Center | Irvine | California | 92868 | United States | Details | |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| UC San Francisco - Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94115 | United States | Details | |
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | United States | Details | |
| University of Oklahoma - Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Sarah Cannon Research Institute - Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | United States | Details | |
| Dell Seton Medical Center at University of Texas | Austin | Texas | 78712 | United States | Details |